GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes.

BRCA1 BRCA2 functional assays hereditary breast/ovarian cancer protein-protein interaction variant of uncertain significance

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
28 Jan 2019
Historique:
received: 14 01 2019
accepted: 22 01 2019
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 31 1 2019
Statut: epublish

Résumé

Genetic testing for

Identifiants

pubmed: 30696104
pii: cancers11020151
doi: 10.3390/cancers11020151
pmc: PMC6406614
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Regional Development Fund
ID : PI16/00563
Organisme : Catalan Government's Strategic Plan for Research and Innovation in Health (PERIS)
ID : 2017SGR496
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG 15547

Déclaration de conflit d'intérêts

P.R. was scientific coordinator of a course on the classification of BRCA gene allele variants sponsored by AstraZeneca (Milan, June 2018).

Références

Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Sci Rep. 2013 Oct 04;3:2854
pubmed: 24092409
EMBO Rep. 2004 Oct;5(10):989-93
pubmed: 15359272
PLoS Genet. 2016 Jun 06;12(6):e1006096
pubmed: 27272900
Hum Mol Genet. 2003 Sep 1;12(17):2121-31
pubmed: 12915465
Genetics. 2015 Jun;200(2):413-22
pubmed: 25823446
J Biol Chem. 1998 Apr 3;273(14):7795-9
pubmed: 9525870
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5134-9
pubmed: 11320250
Curr Opin Genet Dev. 2010 Jun;20(3):315-23
pubmed: 20456937
Hum Mutat. 2011 Dec;32(12):1470-80
pubmed: 21922593
Hum Mutat. 2012 Jan;33(1):8-21
pubmed: 21990134
Cancer Res. 2010 Feb 1;70(3):988-95
pubmed: 20103620
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12078-83
pubmed: 11593018
Hum Mutat. 2014 Nov;35(11):1382-91
pubmed: 25146914
Eur J Intern Med. 2016 Jul;32:65-71
pubmed: 27062684
Hum Mutat. 2012 Aug;33(8):1228-38
pubmed: 22505045
Hum Mol Genet. 2006 Feb 15;15(4):599-606
pubmed: 16403807
Oncogene. 2006 Sep 25;25(43):5864-74
pubmed: 16998501
Mol Cell. 2006 Jun 23;22(6):719-729
pubmed: 16793542
J Med Genet. 2019 Aug;56(8):521-525
pubmed: 30580288
Cancer Res. 2013 Jan 1;73(1):265-75
pubmed: 23108138
Electrophoresis. 1997 Dec;18(15):2714-23
pubmed: 9504803
EMBO J. 2012 Mar 7;31(5):1160-76
pubmed: 22293751
Breast Cancer Res Treat. 2010 Feb;119(3):737-43
pubmed: 19543972
J Clin Oncol. 2014 Jul 1;32(19):2001-9
pubmed: 24733792
Cell. 2002 Jan 25;108(2):171-82
pubmed: 11832208
Blood. 2011 Sep 1;118(9):2430-42
pubmed: 21719596
Hum Mutat. 2013 Mar;34(3):439-45
pubmed: 23161852
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
Am J Hum Genet. 2007 Nov;81(5):873-83
pubmed: 17924331
Hum Mutat. 2008 Nov;29(11):1342-54
pubmed: 18951461
Cancer Res. 2008 May 1;68(9):3523-31
pubmed: 18451181
Oncogene. 2012 Feb 9;31(6):799-804
pubmed: 21725363
J Biol Chem. 2003 Sep 12;278(37):34743-6
pubmed: 12890688
Oncogene. 2006 Feb 23;25(8):1186-94
pubmed: 16205630
Fam Cancer. 2011 Jun;10(2):207-12
pubmed: 21318380
Hum Mutat. 2014 Feb;35(2):151-64
pubmed: 24323938
Nat Methods. 2004 Dec;1(3):255-62
pubmed: 16145770
J Clin Oncol. 2008 Nov 20;26(33):5393-400
pubmed: 18824701
Cancer Res. 2001 Jun 15;61(12):4842-50
pubmed: 11406561
Hum Mol Genet. 2014 Jul 15;23(14):3666-80
pubmed: 24569164
Nat Struct Biol. 2001 Oct;8(10):833-7
pubmed: 11573085
Acta Crystallogr D Biol Crystallogr. 1998 Nov 1;54(Pt 6 Pt 1):1078-84
pubmed: 10089483
Cancer Discov. 2013 Oct;3(10):1142-55
pubmed: 23867111
PLoS One. 2014 Feb 06;9(2):e86924
pubmed: 24516540
Cancer Res. 2005 Jan 15;65(2):417-26
pubmed: 15695382
Hum Mutat. 2018 May;39(5):593-620
pubmed: 29446198
Front Oncol. 2013 Sep 11;3:228
pubmed: 24062981
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6614-9
pubmed: 17420471
Nat Genet. 1996 Dec;14(4):430-40
pubmed: 8944023
Genet Med. 2019 Feb;21(2):293-302
pubmed: 29988080
Nat Struct Mol Biol. 2013 Oct;20(10):1191-8
pubmed: 24013206
Cell Div. 2008 Jan 07;3:1
pubmed: 18179693
EMBO J. 2002 Dec 16;21(24):6755-62
pubmed: 12485996
Mol Biosyst. 2008 Jun;4(6):599-605
pubmed: 18493658
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22
pubmed: 23628597
Science. 2007 May 25;316(5828):1202-5
pubmed: 17525342
Hum Mutat. 2010 Jun;31(6):E1484-505
pubmed: 20513136
Clin Genet. 2013 Nov;84(5):407-14
pubmed: 24025038
Nature. 2018 Oct;562(7726):217-222
pubmed: 30209399
Am J Hum Genet. 2004 Oct;75(4):535-44
pubmed: 15290653
J Biol Chem. 2005 Jun 10;280(23):21854-7
pubmed: 15811849
J Biol Chem. 2002 Jun 14;277(24):22085-92
pubmed: 11927591
Am J Hum Genet. 2018 Feb 1;102(2):233-248
pubmed: 29394989
Science. 2002 Sep 13;297(5588):1837-48
pubmed: 12228710
Radiat Res. 2010 Jul;174(1):1-13
pubmed: 20681793
Hum Mutat. 2012 Nov;33(11):1526-37
pubmed: 22753008
Hum Mutat. 2019 Sep;40(9):1557-1578
pubmed: 31131967
Science. 2011 Oct 28;334(6055):525-8
pubmed: 22034435
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
PLoS One. 2014 Jan 28;9(1):e86836
pubmed: 24489791
J Clin Oncol. 2008 Apr 1;26(10):1657-63
pubmed: 18375895
Cancer Cell. 2011 Dec 13;20(6):797-809
pubmed: 22172724

Auteurs

Laura Caleca (L)

Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. laura.caleca@istitutotumori.mi.it.

Mara Colombo (M)

Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. mara.colombo@istitutotumori.mi.it.

Thomas van Overeem Hansen (T)

Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark. Thomas.Van.Overeem.Hansen@regionh.dk.
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark. Thomas.Van.Overeem.Hansen@regionh.dk.

Conxi Lázaro (C)

Hereditary Cancer Program, Catalan Institute of Oncology. Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, 08900 Barcelona, Spain. conxi.lazaro@gmail.com.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain. conxi.lazaro@gmail.com.

Siranoush Manoukian (S)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. Siranoush.Manoukian@istitutotumori.mi.it.

Michael T Parsons (MT)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane 4029, Australia. Michael.Parsons@qimrberghofer.edu.au.

Amanda B Spurdle (AB)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane 4029, Australia. Amanda.Spurdle@qimrberghofer.edu.au.

Paolo Radice (P)

Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. paolo.radice@istitutotumori.mi.it.

Classifications MeSH